Trade BioNTech BNTX

BioNTech live chart

instrument_fundamentals

Weekly Search
Weekly
Daily
date Close change Change (%) instr__open High Low

instr__news

Webhose 2025 Dec 13, 06:40

Gilder Gagnon Howe & Co. LLC Has $71.08 Million Position in BioNTech SE Sponsored ADR $BNTX - Stock Observer

BioNTech SE
Webhose 2025 Dec 13, 01:14

Bellevue Group AG Raises Stake in BioNTech SE Sponsored ADR $BNTX - Daily Political

BioNTech SE
Webhose 2025 Dec 12, 11:42

Research Analysts Set Expectations for BioNTech Q4 Earnings - Markets Daily

BioNTech SE
Webhose 2025 Dec 12, 09:30

Analysts Set BioNTech SE Sponsored ADR (NASDAQ:BNTX) Target Price at $136.42 - Markets Daily

BioNTech SE
Webhose 2025 Dec 12, 08:10

How Recent Developments Are Rewriting The BioNTech Investment Story

BioNTech SE
Webhose 2025 Dec 11, 14:40

Berenberg Bank Forecasts Strong Price Appreciation for BioNTech (NASDAQ:BNTX) Stock

BioNTech SE
Webhose 2025 Dec 11, 12:44

BioNTech SE (BNTX) is a Buy on Lung Cancer Treatment Prospects: Clear Street

BioNTech SE
Webhose 2025 Dec 11, 06:40

Berenberg Bank Issues Positive Forecast for BioNTech (NASDAQ:BNTX) Stock Price - Daily Political

BioNTech SE
Webhose 2025 Dec 10, 16:18

Did New Gotistobart Data Just Shift BioNTech's (BNTX) Oncology-Led Diversification Narrative? - Simply Wall St News

BioNTech SE
Webhose 2025 Dec 10, 09:10

First Trust Advisors LP Has $35.28 Million Holdings in BioNTech SE Sponsored ADR $BNTX

BioNTech SE
Webhose 2025 Dec 08, 12:10

Temasek Holdings Private Ltd Lowers Holdings in BioNTech SE Sponsored ADR $BNTX

BioNTech SE
Webhose 2025 Dec 08, 00:18

Is BioNTech (NasdaqGS:BNTX) Undervalued After Recent Share Price Weakness? A Fresh Look at Its Valuation

BioNTech SE
Webhose 2025 Dec 07, 18:15

BioNTech, OncoC4 presented data from Phase 3 trial for gotistobart | Markets Insider

BioNTech SE
Webhose 2025 Dec 07, 09:36

25,780 Shares in BioNTech SE Sponsored ADR $BNTX Bought by Bollard Group LLC

BioNTech SE
Webhose 2025 Dec 07, 06:28

BioNTech SE Sponsored ADR (NASDAQ:BNTX) Receives Average Rating of "Moderate Buy" from Analysts

BioNTech SE
Webhose 2025 Dec 06, 20:30

BioNTech and OncoC4 Announce Clinically Meaningful Overall Survival Benefit for Selective Treg Modulator Gotistobart in Patients with Previously Treated Squamous Non-Small Cell Lung Cancer

BioNTech SE
Webhose 2025 Dec 05, 09:37

Dodge & Cox Invests $93.42 Million in BioNTech SE Sponsored ADR $BNTX

BioNTech SE
Webhose 2025 Dec 04, 21:22

BioNTech's (BNTX) Buy Rating Reiterated at Jefferies Financial Group

BioNTech SE
Webhose 2025 Dec 04, 05:00

Other news to note for Dec. 4, 2025 | BioWorld

BioNTech SE
Webhose 2025 Dec 03, 20:23

Promising Biotech Stocks To Consider - December 3rd - Markets Daily

BioNTech SE
Webhose 2025 Dec 03, 01:22

The Bull Case For BioNTech (BNTX) Could Change Following Higher Guidance And Oncology Progress - Learn Why

BioNTech SE
Webhose 2025 Dec 01, 23:22

Vaccine stocks slide as FDA official links COVID vaccines and heart conditions in young men | Morningstar

BioNTech SE
Webhose 2025 Dec 01, 17:35

Vaccine stocks take a hit as FDA official points to link between COVID-19 vaccines and rare heart condition in young men | Morningstar

BioNTech SE
Webhose 2025 Dec 01, 17:09

Vaccine makers fall on FDA memo, Bally's wins bid for NYC casino

BioNTech SE
Webhose 2025 Dec 01, 01:03

BioNTech (BNTX): Assessing Valuation Following Recent Momentum Shift

BioNTech SE
Webhose 2025 Dec 01, 00:16

BioNTech (BNTX) Is Up 7.9% After Raising 2025 Revenue Guidance on Bristol-Myers Collaboration

BioNTech SE
Webhose 2025 Nov 30, 22:16

Evaluating BioNTech (BNTX): Is the Stock Undervalued After Its Recent Uptick?

BioNTech SE
Webhose 2025 Nov 29, 08:36

Virtus Investment Advisers LLC Purchases 1,260 Shares of BioNTech SE Sponsored ADR $BNTX - Stock Observer

BioNTech SE
Webhose 2025 Nov 28, 12:20

Groupama Asset Managment Buys 26,681 Shares of BioNTech SE Sponsored ADR $BNTX - Markets Daily

BioNTech SE
Webhose 2025 Nov 27, 10:52

Legal & General Group Plc Raises Holdings in BioNTech SE Sponsored ADR $BNTX - Markets Daily

BioNTech SE
Webhose 2025 Nov 27, 05:52

Legal & General Group Plc Boosts Stock Position in BioNTech SE Sponsored ADR $BNTX - Stock Observer

BioNTech SE
Webhose 2025 Nov 26, 11:23

Franklin Resources Inc. Acquires 326,556 Shares of BioNTech SE Sponsored ADR $BNTX

BioNTech SE
Webhose 2025 Nov 26, 02:29

BioNTech's (BNTX) "Buy" Rating Reaffirmed at Berenberg Bank - Daily Political

BioNTech SE
Webhose 2025 Nov 26, 01:46

Edmond DE Rothschild Holding S.A. Raises Stock Position in BioNTech SE Sponsored ADR $BNTX - Daily Political

BioNTech SE
Webhose 2025 Nov 26, 00:05

CureVac Announces Voting Results of Extraordinary General Meeting

BioNTech SE
Webhose 2025 Nov 25, 14:30

Berenberg Bank Reaffirms Buy Rating for BioNTech (NASDAQ:BNTX) - Markets Daily

BioNTech SE
Webhose 2025 Nov 22, 08:34

Bank Julius Baer & Co. Ltd Zurich Lowers Stock Holdings in BioNTech SE Sponsored ADR $BNTX

BioNTech SE
Webhose 2025 Nov 21, 10:24

BioNTech SE Sponsored ADR $BNTX Shares Sold by ProShare Advisors LLC - Markets Daily

BioNTech SE
Webhose 2025 Nov 21, 05:24

ProShare Advisors LLC Sells 758 Shares of BioNTech SE Sponsored ADR $BNTX - Stock Observer

BioNTech SE
Webhose 2025 Nov 20, 02:42

Pfizer Is Giving Up on BioNTech. Should You Ditch BNTX Stock Now Too?

BioNTech SE
Webhose 2025 Nov 19, 07:52

Primecap Management Co. CA Reduces Holdings in BioNTech SE Sponsored ADR $BNTX - Stock Observer

BioNTech SE
Webhose 2025 Nov 18, 14:30

BioNTech's (BNTX) "Buy" Rating Reiterated at Berenberg Bank

BioNTech SE
Webhose 2025 Nov 15, 15:20

BioNTech (NASDAQ:BNTX) Shares Gap Down - Should You Sell? - Stock Observer

BioNTech SE
Webhose 2025 Nov 15, 11:56

Mitsubishi UFJ Trust & Banking Corp Sells 17,597 Shares of BioNTech SE Sponsored ADR $BNTX - Markets Daily

BioNTech SE
Webhose 2025 Nov 15, 09:34

A Look at BioNTech (NasdaqGS:BNTX) Valuation Following Pfizer's Complete Stake Sale - Simply Wall St News

BioNTech SE
Webhose 2025 Nov 15, 08:20

Allianz SE Buys 5,080 Shares of BioNTech SE Sponsored ADR $BNTX

BioNTech SE
Webhose 2025 Nov 15, 02:10

A Look at BioNTech (NasdaqGS:BNTX) Valuation Following Pfizer's Share Sale Announcement

BioNTech SE
Webhose 2025 Nov 14, 15:51

BioNTech (NASDAQ:BNTX) Shares Gap Down - What's Next?

BioNTech SE
Webhose 2025 Nov 14, 09:55

Candriam S.C.A. Sells 84,219 Shares of BioNTech SE Sponsored ADR $BNTX

BioNTech SE
Webhose 2025 Nov 14, 06:10

COVID-19 Vaccine: Pfizer Reduces Stake in BioNTech, Marks a Strategic Shift Post-COVID Vaccine Success, ETPharma

BioNTech SE
Webhose 2025 Nov 14, 02:46

Fox Run Management L.L.C. Purchases New Holdings in BioNTech SE Sponsored ADR $BNTX - Daily Political

BioNTech SE

BioNTech news

Latest news

Show more

Info

Spread

1.0663

Spread (%)

1.1163 %

Leverage

1:10

Overnight Interest Buy

-0.0597 %

Overnight Interest Sell

-0.0292 %

Currency

USD

Trading Hours

Markets closed

Friday

14:31 - 20:59

Monday

14:31-20:59

Tuesday

14:31-20:59

Wednesday

14:31-20:59

Thursday

14:31-20:59

instr__analysis_statistics

instr__open

---

instr__close

---

instr__52week_range

--- – ---

instr__market_cap

23083724800

instr__shares_outstand

240455450

instr__earnings_date

0000-00-00

instr__dividend_date

2022-06-17

instr__ex_dividend_date

2022-06-02

instr__forward_annual_dividend_rate

0

instr__forward_annual_dividend_yield

0

instr__eps

-2.78

instrument_learn_more

BioNTech BioNTech SE
BioNTech SE, a biotechnology company, develops and commercializes immunotherapies to treat cancer and infectious diseases in Germany. The company develops BNT111, which is in Phase 2 clinical trial for advance melanoma; BNT113, which is in Phase 2 clinical trial to treat head and neck squamous cell carcinoma; BNT116, which is in Phase I clinical trial for non-small cell lung cancer; BNT142, which is in phase 1/2 clinical trial for multiple solid tumors; BNT151, which is in phase 1/2 clinical trial for solid tumors; BNT152+BNT153, which is in phase 1 clinical trial for solid tumors; and BNT122/RO7198457, which is in Phase 2 clinical trial to treat adjuvant high-risk muscle-invasive urothelial carcinoma, colorectal cancer, pancreatic ductal adenocarcinoma, advance melanoma, as well as in phase 1a/1b clinical trial for advanced/metastatic solid tumors. It also develops BNT211, which is in phase 1 clinical trial to treat CLDN6+ solid tumors; BNT221, phase 1 clinical trial for the treatment of cancer; BNT311/GEN1046 (acasunlimab), which is in phase 3 clinical trial for solid tumors; BNT312/GEN1042, which is in phase 1/2 and 1 clinical trial to treat solid tumors; BNT314/GEN1059, which is in Phase 1/2 clinical trial for advanced or metastatic solid tumors; BNT315/GEN1055, which is in phase 1/2 clinical trial for advanced solid tumors; BNT317, which is in phase 1 clinical trial for advanced solid tumors; BNT327, which is in phase 1/2, 2, and 3 clinical trial to treat small cell lung cancer, advanced/metastatic tnbc, neuroendocrine neoplasm, malignant mesothelioma, EGFR-mutant non-squamous, hepatocellular carcinoma, and advanced solid tumors; and BNT316/ONC-392, which is in phase 1/2, 2, and 3 clinical trial to treat metastatic, non-small cell lung cancer, platinum-resistant ovarian cancer, metastatic castration resistant prostate cancer, and advanced or metastatic solid tumor. BioNTech SE was incorporated in 2008 and is headquartered in Mainz, Germany.

related_instruments

view_all_instruments

latest_education_articles

Show more
Trustpilot